GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS (GENE)

CUSIP: 37185R208

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / SPON ADR 150SHS
Total 13F shares
2,114,179
Share change
-630,480
Total reported value
$2,524,000
Price per share
$1.19
Number of holders
10
Value change
-$740,272
Number of buys
5
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 37185R208?
CUSIP 37185R208 identifies GENE - GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS (GENE) as of Q1 2017

As of 31 Mar 2017, GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS (GENE) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,114,179 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, SABBY MANAGEMENT, LLC, Bank of New York Mellon Corp, CITADEL ADVISORS LLC, UBS Group AG, Cutler Group LP, SIMPLEX TRADING, LLC, LADENBURG THALMANN FINANCIAL SERVICES INC., and MORGAN STANLEY. This page lists 10 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.